GLP-1 based drugs are transforming the treatment of obesity and opening up new avenues for addressing heart disease, addiction, and even Alzheimer’s. Now, three scientists who played key roles in their invention have won a prestigious Lasker Award for biomedical research.

Each year, the Lasker Awards honor a number of medical professionals doing standout work in research and public service. The New York Times has called the awards “the nation’s most prestigious medical prizes.

Three scientists are honored for developing a class of blockbuster weight-loss drugs. Is a Nobel prize on the way?

Half a century of advancements in biomedical science paved the way for today's powerful weight-loss drugs like Ozempic -- so what was that journey like for the scientists involved?

Weight-loss drugs like Ozempic are booming in popularity, but experts warn they aren't silver bullets for obesity.

This year’s prestigious Lasker medical awards recognize a trio of scientists without whom Ozempic and other blockbuster weight-loss drugs might not exist. The work of Joel Habener, a physician-investigator at the Mass General Research Institute and Harvard Medical School professor;

Six individuals have received this year's Lasker Awards in the areas of basic research, clinical research, and public service. Each award carries a stipend of $250,000.